Tampa Company Expands Clinical Trials of Cancer Vaccine
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, is moving forward with clinical trials of a cancer vaccine after getting FDA approval. The company developed the vaccine after decades of research and study. Earlier trials showed promise in larger animals afflicted with melanoma. Now […]
SATLANTIS Wins Award for Best Space Company
A jury composed of members of the European Space Agency (ESA), the Emirates Space Agency (UAESA), German and Emirati investors, the Ministry of Environment, and the Ministry of Foreign Affairs of the Arab Emirates, selected from over 900 applications 40 finalists worldwide, in 4 thematic categories, under the CLIX (Climate Innovations Exchange) initiative of the […]
How the ‘Skim Reaper’ Protects You From Credit Card Skimmers
Houston has been hailed king when it comes to credit card skimmers, and they’re not completely wrong. Houston is a hub for the skimming scam but the reality is they exist everywhere. “My credit card got stolen for the sixth time in a three-year period,” professor Patrick Traynor, with the Department of Computer and Information […]
Morrisville-Based Clinipace Adds Another $10.5M to Its Coffers As It Goes on Hiring Spree
UF startup Clinipace, a global full-service contract research organization (CRO), continues to raise cash as it continues to look for talent. The Morrisville-based CRO has raised an additional $10.56 million in debt, according to a securities filing. That brings its total raised to $14.7 million in a mix of as part of this round opened in […]
SATLANTIS Enters Into Launch Services Agreement With Firefly Aerospace
Firefly Aerospace, Inc., a provider of economical and dependable launch vehicles, spacecraft and in-space services, announced the execution of a Launch Services Agreement with UF startup and UF Innovate | The Hub resident company SATLANTIS, a provider of high-performance payload technologies for Earth observation and remote sensing. Beginning in 2022, SATLANTIS will utilize the Firefly […]
Amadeus Buys Optym’s Flight Network Planning Tech
Amadeus, a travel technology company, is acquiring the airline tech unit of UF startup Optym, a privately-held world leader in new-generation optimization software solutions, for an undisclosed amount. The unit helps airlines with planning and scheduling their flight networks. Optym, privately held and founded in 2000 by University of Florida professor Ravi Ahuja, Ph.D., aims to […]
SharpSpring Implementing “Performance-Based” Workweek
UF startup SharpSpring, Inc., a leading cloud-based marketing automation platform for digital marketing agencies, is changing the way employees view their work schedule by moving from a time-based workweek to a performance-based one. The changes are intended to reward employees who are able to reach their weekly goals without being tied to a typical 40-hour […]
Algernon Signs Novotech Up for Midstage Respiratory Therapy Test
UF startup Algernon Pharmaceuticals has chosen contract research organization (CRO) Novotech to help run its phase 2 idiopathic pulmonary fibrosis and chronic cough trial for its experimental med NP-120 (Ifenprodil). The study is slated to start in the second quarter of 2020, and Algernon will tap Novotech’s experience across the Asia-Pacific region. Also, the CRO […]
Molekule Launches on Amazon, Broadening Consumer Reach and Access to Its Clean Air Technology
UF startup Molekule, the leader in reinventing air purification, announced the availability of its home product line on Amazon. Since launching its first product 2.5 years ago, Molekule has become one of the most-searched-for terms within Amazon’s air purifier category. Available for pre-order immediately, Amazon users now have access to Molekule’s breakthrough Photo Electrochemical Oxidation […]
Sun BioPharma, Inc. Presents SBP-101 Phase 1 Clinical Data
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of people with pancreatic cancer, summarized initial Phase 1 clinical data for SBP-101, which was presented in a poster session at the American Society for Clinical Oncology (ASCO) 2020 Gastrointestinal Cancers Symposium. SBP-101 is a proprietary polyamine analogue designed to […]